Novo Nordisk HCP Video Library
TubeHealth is an independent service and is not affiliated with or endorsed by YouTube or Google.
Data displayed on this page is retrieved via YouTube API Services.
Updated:
Novo Nordisk HCP Video Library Channel Description Snapshot
Channel Description
Specially created for HCPs practicing in the United States, this channel focuses on a variety of products from Novo Nordisk. Keep watching to find out more about Novo Nordisk treatments, including Fiasp® (insulin aspart injection) 100 U/mL; Tresiba® (insulin degludec) injection 100 Units/mL, 200 Units/mL; Ozempic® (semaglutide) injection 0.5 mg 1 mg, or 2 mg; and RYBELSUS® (semaglutide) tablets 7 mg or 14 mg. Novo Nordisk has been driving innovation and change in health care for almost 100 years.
Subscribe to stay up to date on videos for HCPs about Novo Nordisk treatments.
Fiasp®, Ozempic®, RYBELSUS®, and Tresiba® are registered trademarks of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2022 Novo Nordisk All rights reserved. US22OZM00829 August 2022
Subscribe to stay up to date on videos for HCPs about Novo Nordisk treatments.
Fiasp®, Ozempic®, RYBELSUS®, and Tresiba® are registered trademarks of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2022 Novo Nordisk All rights reserved. US22OZM00829 August 2022
About This Page
Methodology: This page displays a snapshot of publicly available creator information retrieved via YouTube API Services.
Snapshot
Snapshot Date:
Data Source: Public data retrieved via YouTube API Services
Data is refreshed at least once every 30 days.